Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19
Clinical trial NCT04405570 · COMPLETED
Trial details
- NCT number
- NCT04405570
- Sponsor
- Ridgeback Biotherapeutics, LP
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-19
- Primary completion
- 2021-02-21
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.